At least one Michigan health system is halting gender-affirming services for young patients, following an executive order ...

One of the main treatments for CPP is the use of gonadotropin-releasing hormone analogs (GnRHa), which help to delay the progression of puberty and can positively influence final adult height ...

England's National Health Service banned the use of puberty blockers for children seeking treatment for gender dysphoria, ...